亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Cysteine Reversal of Neuromuscular Blocking Drugs

*Abstract

During certain surgical procedures, neuromuscular blocking agents must be used.  However, these neuromuscular blocking agents literally paralyze the patient for the time during which they are active.  

 

Because paralysis can interfere with essential bodily functions (e.g. breathing), the physician selects a neuromuscular blocking agent that will be active for only as long as needed but no longer.  For example, when a breathing tube must be inserted into the trachea of a patient a neuromuscular blocking agent is used to relax the tracheal muscles and permit intubation.  However, the neuromuscular blocking agent also relaxes the muscles of the chest causing the patient to stop breathing.  The anesthesiologist must quickly insert the breathing tube into the patient’s trachea and begin ventilation of the lungs.  If the tube cannot be inserted quickly, the physician must intervene with some form of artificial resuscitation or the patient may suffer oxygen deprivation and the associated tissue damage from lack of oxygen.

 

Drs. Savarese and Heerdt have developed a cysteine based solution that rapidly reverses the effects of the neuromuscular by rapidly antagonizing the neuromuscular blocking agent and thus removing the patient from danger and avoiding the need for artificial resuscitation.

 

This work is unpublished although, additional information is available upon executing a confidentiality agreement.

*Licensing
Brian J. Kellybjk44@cornell.edu212-746-6186
其他
None
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备